Randomness and biospecificity: random copolymers are capable of biospecific molecular recognition in living systems.

Biospecific molecular recognition in living systems is known to be based on the lock and key principle as proposed by Emil Fischer. Based on this concept, biospecific polymers have been produced synthetically by attaching biospecific 'keys' to the polymer chain. We postulate that biospecificity can be achieved by alternative means, namely random substitution of a preformed polymer with suitable chemical groups or random copolymerization of suitable functional monomers. Such polymers, we suggest, will contain arrangements of the chemical functions which mimic natural biospecific sites and the probability of occurrence of such arrangements will depend on the average composition of the polymer. In support of this principle, we have developed several functional random copolymer systems which possess a variety of biological properties depending on the type of chemical function. Examples are: polymers possessing anticoagulant properties similar to those of heparin; polymers which interact specifically with components of the immune system; and polymers which, in contact with cells, affect their growth and metabolism. In the case of statistical copolymers possessing 'DNA-like' properties obtained by phosphorylation of hydroxylated polystyrene derivatives, Monte Carlo simulations were used to determine the distribution of phosphodiester (PDE) groups along the chains and to compute the probabilities of occurrence of particular arrangements of PDE found in the 'DNA-like' sites. The results showed that these sites are made up of PDE groups separated by distances that closely match those between the same groups along a generatrix of the DNA double-helix cylinder. These findings offer the prospect of manufacturing polymeric biomaterials endowed with biomimetic character. Moreover, they provide the basis for a hypothesis regarding the appearance of biospecificity at the origin of life, suggesting that biospecific structures may have evolved by natural selection from purely random copolymers. It is likely therefore that biospecificity is a continuous function of randomness, arising from purely statistical distributions of reactivity and evolving into precisely defined structures such as those involved in ligand-receptor interactions.

[1]  R. Larsson,et al.  A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. , 1983, Biomaterials, medical devices, and artificial organs.

[2]  M. Petitou,et al.  The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic Antithrombotics , 1993 .

[3]  A. Poot,et al.  The binding of human blood platelets to fibrinogen-, fibronectin-, and Arg-Gly-Asp-derivatized Sephadex G-10. , 1995, Journal of biomaterials science. Polymer edition.

[4]  R. Jordan,et al.  Fractionation of low molecular weight heparin species and their interaction with antithrombin. , 1979, The Journal of biological chemistry.

[5]  A. Hoffman,et al.  COVALENT BINDING OF BIOMOLECULES TO RADIATION‐GRAFTED HYDROGELS ON INERT POLYMER SURFACES , 1972, Transactions - American Society for Artificial Internal Organs.

[6]  J. Hubbell,et al.  Covalent surface immobilization of Arg-Gly-Asp- and Tyr-Ile-Gly-Ser-Arg-containing peptides to obtain well-defined cell-adhesive substrates. , 1990, Analytical biochemistry.

[7]  S. W. Kim,et al.  Immobilized heparin: spacer arm effects on biological interactions. , 1982, Thrombosis research.

[8]  T. Tuan,et al.  New evidence and new hope concerning endothelial seeding of vascular grafts. , 1992, American journal of surgery.

[9]  J. Feijen,et al.  Advanced Biomaterials in Biomedical Engineering and Drug Delivery Systems , 1996 .

[10]  E. Merrill,et al.  Polyvinyl alcohol--- heparin hydrogel "G". , 1970, Journal of applied physiology.

[11]  J. Courty,et al.  Biological and binding studies of acidic fibroblast growth factor in the presence of substituted dextran. , 1989, Journal of biomaterials science. Polymer edition.

[12]  M. Kazatchkine,et al.  The ability of Sephadex to activate human complement is suppressed in specifically substituted functional Sephadex derivatives. , 1988, Molecular immunology.

[13]  D. Letourneur,et al.  Inhibition by heparin and derivatized dextrans of Staphylococcus aureus adhesion to fibronectin-coated biomaterials. , 1992, Journal of biomaterials science. Polymer edition.

[14]  R. Barbucci,et al.  Preparation and ESCA characterization of poly(vinyl chloride) surface-grafted with heparin-complexing poly(amido amine) chains. , 1982, Biomaterials.

[15]  R. Schnaar,et al.  Covalent attachment of an Arg-Gly-Asp sequence peptide to derivatizable polyacrylamide surfaces: support of fibroblast adhesion and long-term growth. , 1988, Analytical biochemistry.

[16]  K. Yamada,et al.  Dualistic nature of adhesive protein function: fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function , 1984, The Journal of cell biology.

[17]  G. Reach,et al.  Reversible morphological and functional abnormalities of RINm5F cells cultured on polystyrene sulfonate beads. , 1987, Journal of biomedical materials research.

[18]  A. Fischer,et al.  Anticoagulant activity of dextran derivatives. Part II: Mechanism of thrombin inactivation. , 1985, Biomaterials.

[19]  D. Muller,et al.  Affinity chromatography of thrombin on modified polystyrene resins. , 1986, Journal of chromatography.

[20]  R. Rosenberg,et al.  Affinity of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: I. In vitro adsorption studies. , 1983, Biomaterials.

[21]  M. Jozefowicz,et al.  Randomness and Biospecificity : Random Copolymers are Endowed with Biospecific Properties , 1996 .

[22]  J. Brash,et al.  Adsorption of thrombin from buffer and modified plasma to polystyrene resins containing sulphonate and sulphamide arginyl methyl ester groups. , 1988, Biomaterials.

[23]  M. Petitou,et al.  Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. , 1983, Biochemical and biophysical research communications.

[24]  K. Woodhouse,et al.  Interactions of plasminogen and fibrinogen with model silica glass surfaces: adsorption from plasma and enzymatic activity studies. , 1994, Journal of biomedical materials research.

[25]  L. Stanislawski,et al.  Conformational changes of fibronectin induced by polystyrene derivatives with a heparin-like function. , 1993, Journal of biomedical materials research.

[26]  T. Avramoglou,et al.  Derivatized dextran inhibition of smooth muscle cell proliferation. , 1991, Journal of biomaterials science. Polymer edition.

[27]  R. Rosenberg,et al.  Catalysis of the generation of thrombin-antithrombin complex by insoluble anticoagulant polystyrene derivatives. , 1984, Biomaterials.

[28]  M. Kazatchkine,et al.  Molecular weight dependency of the acquired anticomplementary and anticoagulant activities of specifically substituted dextrans. , 1987, Biomaterials.

[29]  M. Samama,et al.  Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins. , 1982, Thrombosis research.

[30]  G. Reach,et al.  RINm5F cell culture on Sephadex derivatives. , 1993, Journal of biomedical materials research.

[31]  B. Ratner,et al.  Surface properties of RGD-peptide grafted polyurethane block copolymers: variable take-off angle and cold-stage ESCA studies. , 1993, Journal of biomaterials science. Polymer edition.

[32]  J. Brash,et al.  Interaction of antithrombin III in purified solution and in plasma with insoluble modified polystyrene , 1993 .

[33]  V. Migonney,et al.  Heparin-like tubings. I. Preparation, characterization and biological in vitro activity assessment. , 1988, Biomaterials.

[34]  M. Sefton,et al.  Properties of a heparin-poly(vinyl alcohol) hydrogel coating. , 1983, Journal of biomedical materials research.

[35]  M. Kazatchkine,et al.  Effect of substituted dextran derivative on complement activation in vivo. , 1995, Biomaterials.

[36]  V. Migonney,et al.  Biospecific polymers: recognition of phosphorylated polystyrene derivatives by anti-DNA antibodies. , 1997, Journal of biomaterials science. Polymer edition.

[37]  M. Mauzac,et al.  Antithrombic activity of some polysaccharide resins. , 1982, Biomaterials.

[38]  C. Boisson-Vidal,et al.  Adsorption of human antibodies to factor VIII:C to insoluble modified polystyrene from plasma , 1991 .

[39]  M. Okuno,et al.  Fibroblast attachment to Arg-Gly-Asp peptide-immobilized poly(γ-methyl L-glutamate) , 1994 .

[40]  J. Apsimon The Total Synthesis of Natural Products , 1973 .

[41]  R. Dutton,et al.  Heparin Bonding on Colloidal Graphite Surfaces , 1963, Science.

[42]  R. Rosenberg,et al.  Adsorption of purified thrombin or antithrombin III for two insoluble anticoagulant polystyrene derivatives: II. Competition with the other plasma proteins. , 1984, Biomaterials.

[43]  M. Mauzac,et al.  Anticoagulant hydrogels derived from crosslinked dextran. Part II: Mechanism of thrombin inactivation. , 1987, Biomaterials.

[44]  D. Letourneur,et al.  Insoluble DNA-like phosphorylated polystyrene: specific interactions with anti-DNA antibodies from systemic lupus erythematosus patients. , 1992, Biomaterials.

[45]  R. Schwartz,et al.  Monoclonal anti‐cardiolipin antibodies bind to DNA , 1984, European journal of immunology.

[46]  M. Crépin,et al.  Inhibitory effect of substituted dextrans on MCF7 human breast cancer cell growth in vitro , 1992, Anti-cancer drugs.

[47]  F. Macritchie Proteins at interfaces. , 1978, Advances in protein chemistry.

[48]  D. Muller,et al.  Tyrosyl sulfamide derivatives as ligands for affinity adsorption of anti FVIII antibodies. , 1994, Journal of biomaterials science. Polymer edition.

[49]  D. Barritault,et al.  Derivatized dextrans mimic heparin as stabilizers, potentiators, and protectors of acidic or basic FGF , 1992, Journal of cellular physiology.

[50]  V. Migonney,et al.  DNA‐like and phospholipid‐like phosphorylated polystyrenes: Characterization, distribution of functional groups, and calcium complexation properties , 1994 .

[51]  M. Jozefowicz,et al.  Anticoagulant activity of amino acid modified polystyrene resins: influence of the carboxylic acid function. , 1983, Biomaterials.

[52]  A. Fischer,et al.  Antithrombic properties of insoluble modified polystyrene: Part I. , 1984, Thrombosis research.

[53]  M. Mauzac,et al.  Anticoagulant hydrogels derived from crosslinked dextran. Part I: Synthesis, characterization and antithrombic activity. , 1987, Biomaterials.

[54]  Erkki Ruoslahti,et al.  Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule , 1984, Nature.

[55]  D. Stampe,et al.  Isolation of factor IX concentrates for clinical use by ion-exchange chromatography and ammonium sulphate precipitation. , 1986, Journal of chromatography.

[56]  J. Courty,et al.  Affinity chromatography of fibroblast growth factors on substituted polystyrene. , 1990, Journal of chromatography.

[57]  A. D. Litmanovich Change of polymer reactivity in the course of macromolecular reaction , 1980 .

[58]  V. Migonney,et al.  Heparin-like tubings. II. Mechanism of the thrombin-antithrombin III reaction at the surface. , 1988, Biomaterials.

[59]  D. Williams,et al.  Biocompatibility of tissue analogs , 1985 .

[60]  T. Avramoglou,et al.  Inhibitory effect of functional dextrans on rat arterial smooth muscle cell growth in vitro , 1994 .

[61]  D. Labarre,et al.  Complement activation and adsorption of protein fragments by functionalized polymer surfaces in human serum. , 1992, Biomaterials.

[62]  V. Migonney,et al.  Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions. , 1988, Biomaterials.

[63]  Y. Sultan,et al.  Human umbilical vein endothelial cell culture on heparin-like microcarriers. , 1993, Journal of biomedical materials research.

[64]  J. Jozefonvicz,et al.  Affinity of antithrombin III for insoluble modified polystyrene. , 1987, Thrombosis research.

[65]  J. Andrade,et al.  Vroman effects, techniques, and philosophies. , 1991, Journal of biomaterials science. Polymer edition.

[66]  D. Labarre,et al.  Heparin-like activity of insoluble sulphonated polystyrene resins. Part III: Binding of dicarboxylic amino acids. , 1987, Biomaterials.

[67]  J. Monod Le hasard et la nécessité , 1970 .

[68]  M. Mauzac,et al.  Anticoagulant activity of dextran derivatives. Part I: Synthesis and characterization. , 1984, Biomaterials.

[69]  D. Letourneur,et al.  Antiproliferative capacity of synthetic dextrans on smooth muscle cell growth: the model of derivatized dextrans as heparin-like polymers. , 1993, Journal of biomaterials science. Polymer edition.

[70]  M. Kazatchkine,et al.  Anticomplementary activity of dextran derivatives. , 1985, Biomaterials.

[71]  D. Muller,et al.  Thrombin purification by one-step preparative affinity chromatography on modified polystyrenes. , 1986, Journal of chromatography.